Schistosomiasis control: keep taking the tablets.Trends Parasitol. 2004 Feb; 20(2):92-7.TP
Abstract
Despite the limited reports of praziquantel resistance, the relative success of chemotherapy-based control programmes for schistosomiasis has prompted overdue efforts to expand the use of cheap, generic, praziquantel in sub-Saharan Africa. The likely impact of such programmes on the development and spread of praziquantel resistance is uncertain, but this possibility reinforces the need for monitoring the spectrum of praziquantel sensitivity of schistosome populations and for an improved knowledge of the precise targets for the action of the drug. The search for alternatives to praziquantel and other tools for control of schistosomiasis must continue.
Links
MeSH
Pub Type(s)
Journal Article
Research Support, Non-U.S. Gov't
Review
Language
eng
PubMed ID
14747023
Citation
Hagan, Paul, et al. "Schistosomiasis Control: Keep Taking the Tablets." Trends in Parasitology, vol. 20, no. 2, 2004, pp. 92-7.
Hagan P, Appleton CC, Coles GC, et al. Schistosomiasis control: keep taking the tablets. Trends Parasitol. 2004;20(2):92-7.
Hagan, P., Appleton, C. C., Coles, G. C., Kusel, J. R., & Tchuem-Tchuenté, L. A. (2004). Schistosomiasis control: keep taking the tablets. Trends in Parasitology, 20(2), 92-7.
Hagan P, et al. Schistosomiasis Control: Keep Taking the Tablets. Trends Parasitol. 2004;20(2):92-7. PubMed PMID: 14747023.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Schistosomiasis control: keep taking the tablets.
AU - Hagan,Paul,
AU - Appleton,Christopher C,
AU - Coles,Gerald C,
AU - Kusel,John R,
AU - Tchuem-Tchuenté,Louis Albert,
PY - 2004/1/30/pubmed
PY - 2004/7/30/medline
PY - 2004/1/30/entrez
SP - 92
EP - 7
JF - Trends in parasitology
JO - Trends Parasitol
VL - 20
IS - 2
N2 - Despite the limited reports of praziquantel resistance, the relative success of chemotherapy-based control programmes for schistosomiasis has prompted overdue efforts to expand the use of cheap, generic, praziquantel in sub-Saharan Africa. The likely impact of such programmes on the development and spread of praziquantel resistance is uncertain, but this possibility reinforces the need for monitoring the spectrum of praziquantel sensitivity of schistosome populations and for an improved knowledge of the precise targets for the action of the drug. The search for alternatives to praziquantel and other tools for control of schistosomiasis must continue.
SN - 1471-4922
UR - https://www.unboundmedicine.com/medline/citation/14747023/Schistosomiasis_control:_keep_taking_the_tablets_
L2 - https://linkinghub.elsevier.com/retrieve/pii/S1471492203003222
DB - PRIME
DP - Unbound Medicine
ER -